Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Gender affects wool traits in sheep, with males and females showing differences in skin proteins related to wool growth.

A scalp biopsy revealed systemic amyloidosis in a woman who initially seemed to have a common hair loss condition.

The SLICK1 allele in Holstein heifers affects hair and immune traits without altering prolactin signaling.

Loss of Dnmt3a and Dnmt3b increases aggressive skin tumors by affecting PPAR-γ.

Suppressing ODC activity reduces tumor growth in hair follicles.

The study found new details about human hair growth and suggests that preventing a specific biological pathway could potentially treat hair graying.

A specific gene mutation in KRT86 is linked to hair disorder in a Chinese Han family.

Tissue-specific variation in mutant load complicates genetic counseling and prenatal diagnosis.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Deep learning models can analyze scalp diseases effectively.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Certain miRNAs may play a role in sheep hair follicle development, which could help improve wool production.

Truncated LTBP-1 disrupts TGF-beta signaling, affecting hair growth.

Using both vertical and transverse sections for alopecia biopsies improves diagnosis without extra cost.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Certain proteins might predict surgical success in trigeminal neuralgia treatment.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

IL-17 and certain immune cells are linked to more severe alopecia areata.

A specific gene region can control targeted and responsive gene expression in mice, useful for skin disorder treatments.

The Thr1022Ala variant in the hairless gene is not a disease-causing mutation.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

The research suggests that a specific skin gene can be controlled by signals within and between cells and is wrongly activated in certain skin diseases.

A new method, iSiMPRe, effectively identifies key protein regions in cancer genes, highlighting potential drug targets.

Balding scalps show different gene expressions affecting hair growth compared to non-balding scalps.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Mutant cells in hair follicles are influenced by their location and interactions with surrounding cells.

Truncated LTBP-1 disrupts TGF-β signaling, affecting hair growth.